MedPath

Computerized Treatment for Social Anxiety

Not Applicable
Completed
Conditions
Social Anxiety Disorder
Registration Number
NCT03101553
Lead Sponsor
Florida State University
Brief Summary

The present study aims to examine the feasibility of a computerized treatment for social anxiety disorder. To evaluate the efficacy of the IBM protocol the investigators have developed in reducing evaluation and social threat biases, they will conduct a two-arm randomized controlled trial. Individuals with a diagnosis of social anxiety disorder (N = 50) will be randomized to one of two conditions: 1) IBM or 2) progressive muscle relaxation. Each condition will consist of eight 25 minute treatment sessions. Participants will complete two sessions per week for four weeks and will be administered assessments at pre-treatment, one week post-treatment and at 3-month follow-up. It is hypothesized that: 1) IBM will lead to greater reductions in social anxiety symptoms than the PMR condition; 2) IBM will lead to greater reductions in depression and anxiety than the PMR condition; 3) IBM will lead to greater reductions in threat interpretations and greater increases in benign interpretations than the PMR condition; 4) The effects of condition on social anxiety symptoms will be mediated by changes in social anxiety-related interpretation bias; and 5) The effects of condition will be maintained at the 3-month follow-up assessment.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
65
Inclusion Criteria
  • Current diagnosis of Social Anxiety Disorder according to DSM-5 criteria
  • SPIN score greater than or equal to 30
  • Must report sufficient motivation to complete treatment (i.e., score of at least 5 on a 10 point scale (0 = no motivation and 10 = extreme motivation))
Exclusion Criteria
  • Concurrent psychotherapy or treatment for social anxiety disorder
  • Clinically significant suicidality
  • Current Alcohol Use Disorder of "Severe" severity or higher
  • Current Non-alcohol Substance Use Disorder of "Moderate" severity or higher
  • Recent changes (less than four weeks) in psychiatric medication
  • History of psychotic symptoms
  • May not have participated in a similar computerized treatment program

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Social Phobia Inventory (SPIN; Davidson, 1995)change from baseline at one-week post treatment and 3-months post-treatment

Measures past-week social anxiety symptom severity

Secondary Outcome Measures
NameTimeMethod
Beck Depression Inventory (BDI-II; Beck, Steer, & Brown, 1996)change from baseline at one-week post treatment and 3-months post-treatment

Measures depressive symptom severity

Beck Anxiety Inventory (BAI; Steer & Beck, 1997)change from baseline at one-week post treatment and 3-months post-treatment

Measure anxious symptom severity

Interpretations Questionnaire-modified (IQ-modified; Buhlmann et al., 2002)change from baseline at one-week post treatment and 3-months post-treatment

Measure of strength of evaluation related threat interpretation bias

Trial Locations

Locations (1)

Florida State University, Department of Psychology

🇺🇸

Tallahassee, Florida, United States

Florida State University, Department of Psychology
🇺🇸Tallahassee, Florida, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.